← All trials
NCT01421212
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 1999
- Primary completion
- Feb 1, 2002
- Completion date
- Feb 1, 2002
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Biotest PharmaceuticalsLead sponsor
- Mayo ClinicOverall official - principal investigator
- University of FloridaOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- University of MiamiOverall official - principal investigator
- University of MichiganOverall official - principal investigator
- University of North Carolina at Chapel HillOverall official - principal investigator
- Virginia Commonwealth UniversityOverall official - principal investigator
- University of RochesterOverall official - principal investigator
- Columbia UniversityOverall official - principal investigator
- Rush UniversityOverall official - principal investigator
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.